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Impaired Epidermal Ceramide Synthesis Causes
Autosomal Recessive Congenital Ichthyosis and
Reveals the Importance of Ceramide Acyl Chain
Length
Katja-Martina Eckl1,2, Rotem Tidhar3, Holger Thiele4, Vinzenz Oji5, Ingrid Hausser6, Susanne Brodesser7,8,
Marie-Luise Preil9, Aysel O¨nal-Akan1, Friedrich Stock10, Dietmar Mu¨ller10, Kerstin Becker1, Ramona Casper1,
Gudrun Nu¨rnberg4, Janine Altmu¨ller4, Peter Nu¨rnberg4,8, Heiko Traupe5, Anthony H. Futerman3 and
Hans C. Hennies1,2,8
The barrier function of the human epidermis is supposed to be governed by lipid composition and organization
in the stratum corneum. Disorders of keratinization, namely ichthyoses, are typically associated with disturbed
barrier activity. Using autozygosity mapping and exome sequencing, we have identified a homozygous missense
mutation in CERS3 in patients with congenital ichthyosis characterized by collodion membranes at birth,
generalized scaling of the skin, and mild erythroderma. We demonstrate that the mutation inactivates ceramide
synthase 3 (CerS3), which is synthesized in skin and testis, in an assay of N-acylation with C26-CoA, both in
patient keratinocytes and using recombinant mutant proteins. Moreover, we show a specific loss of ceramides
with very long acyl chains from C26 up to C34 in terminally differentiating patient keratinocytes, which is in line
with findings from a recent CerS3-deficient mouse model. Analysis of reconstructed patient skin reveals
disturbance of epidermal differentiation with an earlier maturation and an impairment of epidermal barrier
function. Our findings demonstrate that synthesis of very long chain ceramides by CerS3 is a crucial early step for
the skin barrier formation and link disorders presenting with congenital ichthyosis to defects in sphingolipid
metabolism and the epidermal lipid architecture.
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INTRODUCTION
The barrier function of the human epidermis is localized to the
outermost layer, the stratum corneum. Its main tasks comprise
protection of the organism from intrusion of pathogens and
other exogenous influences as well as from dehydration
through excessive transepidermal water loss. The stratum
corneum is composed of compact lamellar structures mounted
by cornified envelopes, which derive from terminally differ-
entiated keratinocytes, and a typical pattern of lipids that are
secreted into the lamellar interspaces and make up the lipid
envelope (Lazo et al., 1995; Marekov and Steinert, 1998). The
stratum corneum was thus described as a wall composed of
bricks (corneocytes) and mortar (lipids) (Elias, 1987).
The lamellar lipids consist of approximately equal amounts
of ceramides, cholesterol, and free fatty acids. Early in vitro
experiments demonstrated that the permeability and integrity
of bilayered structures is crucially influenced by the inclusion
of ceramides (Lopez et al., 1999). Studies of the human
stratum corneum identified more than 11 different types of
ceramides (Masukawa et al., 2008; van Smeden et al., 2011),
with very typical structures that are unique or rarely found in
other tissues and species: in esterified o-hydroxy ceramides
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with a sphingosine, phytosphingosine, or hydroxysphingosine
base, linoleic acid is ester-linked to a very long acyl chain
ceramide with XC30. Recent in vitro data have pointed out
the importance of long hydrophobic chains of ceramides to
maintain the skin barrier function (Janusˇova´ et al., 2011), and
an analysis of the lipid matrix in situ has shown that the
human skin barrier is organized by stacked bilayers of fully
extended ceramides and cholesterol molecules associated
with the sphingoid base (Iwai et al., 2012).
The activity of the epidermal permeability barrier is typi-
cally compromised in several keratinization disorders, in
particular ichthyoses, disorders affecting all or most of the
skin with scaling, hyperkeratosis, and/or erythroderma
(Bouwstra and Ponec, 2006; Schmuth et al., 2007; Elias
et al., 2008). Autosomal recessive congenital ichthyosis
(ARCI) is a heterogeneous group of rare, severe disorders
with an approximate prevalence of 1:100,000 (Oji et al.,
2010). Mutations associated with ichthyosis were described in
more than 40 genes until today. Several phenotypes presenting
with ichthyosis, however, cannot be attributed to mutations in
one of these genes. Moreover, the pathogenic context of these
disorders remains elusive in many cases. Here we have
identified mutations in CERS3, the gene encoding ceramide
synthase 3, as a cause of ARCI. The impairment of enzyme
activity leads to a disturbed epidermal permeability barrier
function and indicates the important role of ceramides with
very long acyl chains in differentiating keratinocytes.
RESULTS
Identification of mutations in CERS3
We have identified a large family with congenital ichthyosis
from Germany with multiple consanguinity (Figure 1). The
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Figure 1. Phenotype and pedigree. (a) Clinical characterization of patient VII:3 at the age of (i) 6 days, (ii and iii) 3 years, and (iv) 7 years. The girl was born as
collodion baby and developed a moderate lamellar ichthyosis with pronounced keratotic lichenification with a prematurely aged appearance. (v) Hematoxylin
and eosin (H&E) staining of skin sections demonstrated compact orthohyperkeratosis with mild acanthosis. (b) The pedigree contains multiple consanguinity.
Question marks denote connections where the exact relationship is unknown. Individuals marked with a bar were clinically investigated by one of us. Subjects
marked with þ or # sign were included in the linkage analysis and samples from VI:4, VI:13, and VII:1 in the exome sequencing.
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pedigree comprised several branches with a total of nine
individuals diagnosed with ARCI, five of whom seen by us.
The girl VII:3 was investigated in detail over her lifetime
(Figure 1a). At birth, she presented an extreme ectropion and
eclabium with collodion membranes, which rapidly resolved
within 1 week. Since then, she showed a moderate lamellar
ichthyosis with mild erythroderma, with an improvement in
the summer period. In addition, she reported hypohidrosis, but
sweating was possible on the back of her nose. At the age of
3 years, she showed severe scaling of the scalp and a
pronounced keratotic lichenification with a prematurely aged
appearance. She suffered from repeated uncomplicated bac-
terial and pityrosporum infections of the skin on her back and
from pruritus. At 7 years of age, the scaling was lighter in color
and milder and she exhibited exacerbated erythroderma.
Strong keratotic lichenification was still present. History of
atopic diseases was negative. Light microscopy revealed a
moderate and compact orthohyperkeratosis with hyperplastic,
papillomatous epidermis, and mild acanthosis (Figure 1a). It is
noteworthy that the patient was never treated with systemic
retinoids but was advised to take a daily bath with small
amounts of NaHCO3 as a bath additive to carry out mechan-
ical scale removal with the help of a glove while still in the
bath, and to apply supportive emollients containing, e.g., 5%
dexpanthenol and up to 2% urea to the skin afterward. This
treatment strategy, which is in line with the recommendations
from the literature (Oji and Traupe, 2009), is aimed at
ameliorating the phenotype and not known to alter the type
of the disease within the spectrum of clinical presentations of
congenital ichthyosis.
We received written informed consent from all individuals
enrolled. The study was approved by the institutional ethics
committee and followed the Declaration of Helsinki Princi-
ples. We extracted DNA from peripheral blood samples of 19
probands and analyzed known genes for ARCI without a
finding. We then used samples from 15 family members
(Figure 1b) for linkage analysis using the Affymetrix GeneChip
Human Mapping 250K Sty Array Set. Genome-wide analysis
with 20,000 markers assuming three separate consanguineous
families gave only one significant finding, with a LOD score of
4.2, which increased to 6.9 in a refined analysis of the interval
using all markers from the array set. The overlapping homo-
zygous interval between rs12101356 and the most telomeric
marker on chromosome 15q, rs11637017, was 3.4 Mb in
length and contained 54 genes and transcripts.
In parallel, we performed whole exome sequence analysis
using samples from three family members, two affected and
one obligatory heterozygote (see Supplementary Materials and
Methods online). The mean sequence coverage was 90x, 88%
of target sequences were covered at least 10-fold, and 76% at
least 30-fold. After filtering against public databases of known
variants in the human genome such as Single Nucleotide
Polymorphism Database (dbSNP) or 1,000 Genomes, we
found two variants in the interval on 15q26-qter, in
ENSG00000223792 and CERS3. Only one variant, c.43T4C
in exon 4 of CERS3, was consistent with autozygosity. Analysis
of this variant in the whole family using conventional
sequence analysis confirmed full cosegregation of the
mutation (Supplementary Figure S1 online), and the mutation
was not found on 200 chromosomes from control individuals.
Next, we analyzed samples from 80 unrelated individuals
diagnosed with ARCI who did not have mutation findings in
previously known candidate genes, but we did not identify
another mutation in CERS3 in these samples. The mutation
results in a codon exchange p.Trp15Arg in CerS3, also known
as longevity assurance gene-1 (LAG1) homolog-3. The residue
Trp15 is particularly conserved, both through the family
of human LAG1 proteins and in orthologous proteins
(Supplementary Figure S2 online), as represented by a con-
servation score of 9 (highly conserved) in ConSurf (Ashkenazy
et al., 2010). The mutation is predicted to be damaging with a
SIFT (Sorting Intolerant From Tolerant) score (Ng and Henikoff,
2001) of 0 and a PolyPhen score (Adzhubei et al., 2010)
of 0.998.
Gene expression analysis in CerS3-deficient skin
To further characterize the importance of the mutation
p.Trp15Arg, we extracted RNA from cultured keratinocytes
and quantified CERS3 transcripts with real-time reverse-tran-
scriptase–PCR. CERS3 mRNA amounts were mildly reduced to
70% in patient cells. We then analyzed the expression
of CerS3 and several key components of terminally differen-
tiating keratinocytes using immunohistochemistry on sections
from patients and controls (Supplementary Materials and
Methods online). We observed the synthesis of CerS3 in the
granular layer of the epidermis and in particular in the
transition zone between stratum granulosum and stratum
corneum (Figure 2a–c). The specificity of the signal was
confirmed by analyzing reconstructed skin deficient for CerS3
(Supplementary Figure S3 online). Signals of CerS3 in sections
from patient epidermis were slightly reduced but clearly
present in accordance with our results from RNA quantitation.
They were broader in patient skin and also visible in the
stratum corneum (Figure 2b and c). We also observed a partly
upregulated and broadened expression of involucrin, loricrin,
and filaggrin in patient skin (Figure 2d). Expression of
structural proteins of basal and suprabasal keratinocytes, e.g.
keratins, was unchanged (Figure 2e). The expression of 12R-
lipoxygenase (12R-LOX) was clearly upregulated in patient
skin and also visible deep in the spinous layer, in contrast to
control sections, where it was only present in the upper
granular layer (Figure 2f). Relative quantitation of transcripts
from ALOX12B and ALOXE3, the genes for the two epidermal
lipoxygenases 12R-LOX and eLOX-3, showed that their
amounts were strongly increased to 232% and 149%, respec-
tively, in patient keratinocytes compared with terminally
differentiated control keratinocytes.
Impairment of very long acyl chain ceramide synthesis
CerS3 specifically synthesizes very long acyl chain ceramides
with lengths of XC26. We have therefore analyzed the
activity of protein lysates from differentiated control and
patient keratinocytes toward C26–acyl–coenzyme A (CoA),
demonstrating clearly reduced levels of C26 ceramide
synthesis with patient cell homogenates (Figure 2g). Next,
we cloned wild-type and mutant (Trp15Arg) CERS3 and
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overexpressed the constructs in human embryonic kidney
(HEK) cells. Both wild-type and mutant CerS3 were synthe-
sized in these cells (Figure 2h); however, amounts of mutant
enzyme were reduced somewhat compared with wild type.
Homogenates of HEK cells expressing wild-type CERS3
showed N-acylation using C26–CoA, which was almost
completely lacking in lysates from HEK cells expressing
mutant CERS3 (Figure 2i). In order to determine the effects
of CerS3 impairment in our patients, we further analyzed the
levels of free (not protein-bound) and protein-bound cera-
mides in terminally differentiating keratinocytes from the
patient compared with keratinocytes isolated from control
subjects matched in age, skin type, and origin using liquid
chromatography/tandem mass spectrometry (LC-MS/MS).
These studies revealed a strong lack of very long chain
ceramides in patient keratinocytes (Figure 3), as shown for
nonhydroxylated and nonesterified hydroxylated ceramides,
o-hydroxylated ceramides esterified with linoleate (EOS), as
well as protein-bound o-hydroxylated ceramides. The
decrease was most obvious for nonhydroxylated and hydro-
xylated ceramides with C26:0 and longer fatty acyl chains
(Po104 for C30:0), for XC30:0 chain EOS ceramides
(Po102 for C34:0), and for XC30:0 chain protein-bound
hydroxylated ceramides (Po105).
Disturbed epidermal differentiation and impaired epidermal
barrier function
To study the consequences of lack of long chain ceramides,
we further analyzed the morphology of patient skin. Ultra-
structural analysis of skin biopsy specimens of patients VII:1
and VII:3 showed mild acanthosis and moderate to strong
orthohyperkeratosis with cleft-like inclusions in the stratum
corneum, possibly originating from unaccomplished vesicular
trafficking due to not properly processed neutral lipids and
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Figure 2. Synthesis and activity of ceramide synthase 3 (CerS3). (a) Specific expression of CERS3 in the uppermost layer of the stratum granulosum and the transit
zone to the stratum corneum in healthy skin as shown by immunohistochemistry with and without bright field depiction of the epidermis. (b–f) CerS3 and
markers of epidermal differentiation in healthy (upper part) and patient skin (lower part). (b, c) Analysis of CerS3 with two different antibodies showed distinctive
expression in the upper stratum granulosum in healthy skin in contrast to more diffuse expression in the granular and horny layers in the patient sample. Expression
of (d) involucrin (IVL) was elevated and broader in patient skin. (e) Keratin 10 (K10) was unchanged in patient samples. Detection of (f) 12R-lipoxygenase
(12R-LOX) was markedly broadened in the patient sample. Antibodies: green, 4’,6-diamidino-2-phenylindole (DAPI): blue. Scale bars¼25mm. (g–i) Ceramide
synthase activity. (g) Intrinsic CerS3 was assayed using C26–coenzyme A (CoA) in homogenates from primary keratinocytes and lipids were separated by thin layer
chromatography. N¼ 3. (h) Western blot analysis confirmed expression of recombinant CerS3 in human embryonic kidney (HEK) cells and showed slightly
reduced amounts of mutant CerS3 compared with wild type (arrow). The upper band seen here is supposed to represent an alternatively glycosylated form of CerS3
(Laviad et al., 2012; asterisk). (i) Overexpression of CerS3 indicated almost complete loss of enzyme activity caused by mutation p.Trp15Arg in vitro.
NT, transfection control. Means±SD; N¼ 3.
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partly containing melanosomal remnants, and irregular vesi-
cular structures in the granular layer (Figure 4a). Unfortu-
nately, the quality of the fixed material obtained was
insufficient for more detailed studies and the family did not
consent to provide fresh skin specimens. However, here we
did not find a clear clue to a premature lamellar body front
in lower granular layers as there were no morphological
hallmarks for keratinocyte maturation arrest, which is in
contrast to the findings reported in CerS3-deficient mice
(Jennemann et al., 2012).
We then used organotypic cell cultures to model the patient
skin. We cultured keratinocytes and fibroblasts isolated from a
punch biopsy of patient VII:3 and established three-dimen-
sional full-thickness skin models consisting of a dermal matrix
with fibroblasts and an epidermal compartment of keratino-
cytes. Disease models represented the morphological features
of patient skin (Supplementary Figure S4 online). The analysis
clearly illustrated the presence of CerS3 in the upper granular
layer and the stratum corneum in control and patient models,
where the expression was broader and extended to earlier
epidermal layers (Figure 4c). Characterization of skin models
with markers of basal and suprabasal epidermal architecture
did not show clear changes. Analysis of markers for keratino-
cyte terminal differentiation demonstrated earlier maturation
and partly stronger expression (Figure 4d and e). Electron
microscopy of patient skin models demonstrated a thickened,
compact stratum corneum with inhomogeneous lamellae and
regular-appearing cornified cell envelopes and showed
reduced quantities of keratohyalin and only single lamellar
bodies in upper suprabasal layers. Fusion of lamellar bodies in
the transition zone was not obvious and multiple lipid droplets
and other vesicular inclusions were visible in the stratum
corneum (Figure 4b). Taken together, these findings point to
an immature cornification process. To analyze the epidermal
barrier function, we used a penetration assay with the water-
soluble fluorescent dye Lucifer Yellow on reconstructed skin.
The assays revealed reduced permeability barrier activity in
patient models compared with control models (Figure 4f
and g). Barrier impairment, however, was noticeably milder
than in ichthyosis skin models deficient for transglutaminase-1
or 12R-LOX (Eckl et al., 2011).
DISCUSSION
We have identified a homozygous mutation in CERS3 as a
cause for congenital ichthyosis using a combined strategy of
autozygosity mapping and exome sequencing. Ceramide
synthases contain two common motifs, a homeobox (Hox)
domain (residues 83–127 in CerS3) and a TRAM, LAG1,
and CLN8 (TLC) domain (residues 130–331). Directed
experiments in members of the ceramide synthase protein
family suggested the active site in the Lag1p motif, which is
part of the TLC domain (Kageyama-Yahara and Riezman,
80
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Figure 3. Loss of very long acyl chain ceramides in patient keratinocytes. Free and protein-bound ceramides extracted from differentiated keratinocytes from
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2006; Spassieva et al., 2006). A functional motif adjacent
to Hox and TLC domains is essential for enzyme activity;
on the other hand, a major part of the Hox domain appears
to be dispensable (Mesika et al., 2007). A motif of B30
residues in the N-terminal domain of CerS3 and particularly
the tryptophan residue at position 15 are extremely con-
served, pointing to the importance of the domain for protein
function.
CerS3 belongs to the protein family of ceramide synthases
based on their homology with yeast LAG1p (Mizutani et al.,
2006; Rabionet et al., 2008). Ceramide synthases form
dihydroceramide from sphinganine by N-acylation of the
sphingoid base (Pewzner-Jung et al., 2006; Teufel et al.,
2009; Levy and Futerman, 2010; Mullen et al., 2012), and
six human ceramide synthases can be differentiated by their
tissue specificity and the specificity for certain acyl–CoA chain
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Figure 4. Morphological characterization of patient skin and disease models. (a) Ultrastructural analysis of skin biopsy specimens of patients VII:1 and VII:3
showed mild acanthosis and moderate to strong orthohyperkeratosis. Cleft-like inclusions (C), possibly originating from unprocessed neutral lipids and partly
containing melanosomal remnants, were frequently visible in horny lamellae, and irregular vesicular structures (V), partly with melanosomes, were present in the
granular layer. Scale bars¼ 2mm (i), 1mm (ii), 500 nm (iii). (b) Reconstructed skin of patient VII:3 showed a compact, thickened stratum corneum with
inhomogeneous lamellae and inconspicuous cornified cell envelopes. Lipid droplets (L) and vesicular inclusions (V) were frequently visible in the stratum
corneum. Numbers of keratohyalin granules (k) and lamellar bodies (Lbs) were reduced and irregularly distributed in suprabasal layers. Scale bars¼2.5mm (i and
ii), 250 nm (iii). (c–e) Reconstructed skin was characterized by antibodies against markers of epidermal differentiation. (c) Ceramide synthase 3 (CerS3) is present in
upper granular and horny layers in normal models (upper part) and extended to earlier layers in disease models (lower part). (d) Loricrin (Lor) and (e) filaggrin
(Flg) were present in layers of differentiated keratinocytes in controls (upper part) and also visible in earlier layers in disease models (lower part). Scale bar¼25mm.
(f, g) Reconstructed skin was used for dye penetration assays with Lucifer Yellow. Compared with (f) healthy skin, the permeability barrier function is
reduced in (g) disease models as shown by visualization of Lucifer Yellow (left) and overlay with 4’,6-diamidino-2-phenylindole (DAPI) staining (right). Scale
bars¼ 75mm (f), 25mm (g).
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lengths. CERS3 is mainly expressed in testis and the skin; and
CerS3 and CerS4 are the major ceramide synthases of the skin
(Laviad et al., 2008). CerS3 is exceptional as it is able to
metabolize an extended spectrum of very long acyl chains
(Mizutani et al., 2008). Epidermal keratinocytes are unique
with regard to the presence of certain ceramide species and
the importance of very long chain fatty acids. We detected the
major defect in patient cells toward ceramides with acyl chain
lengths XC26 and up to C36. We found the loss of very long
chain ceramides in various ceramide species and both in free
and protein-bound ceramides. Our findings are in line with
the assumption that EOS ceramides are generated from free
hydroxylated ceramides in the epidermis and are essential for
the binding of ceramides to cornified envelope proteins
(Doering et al., 1999; Nemes et al., 1999; Uchida and
Holleran, 2008). Human CerS3 is mainly expressed in the
transition zone between granular layer and stratum corneum,
and we found the specific failure in ceramide synthesis only in
terminally differentiated patient keratinocytes (data not
shown). We detected reduced levels of mutant CerS3
synthesis in vitro; however, the protein is clearly present and
the reduction in protein levels alone probably cannot explain
the loss of activity. Thus, we suggest that the deficit of very
long chain ceramides is mainly due to a vast inactivation of
CerS3. Residual activity of mutant CerS3 in vivo could be
involved in the observed synthesis of small amounts of very
long chain ceramides in patient cells. Moreover, some limited
compensation for missing CerS3 activity might take place
through other members of the human ceramide synthase
family such as CerS2, which can synthesize C22–C26 cer-
amides, the latter although to a limited extent.
The broadened expression of key components of terminal
keratinocyte differentiation, in contrast to normal expression
of structural proteins of basal and suprabasal keratinocytes,
indicates a disturbed epidermal differentiation and a prema-
ture keratinization resulting from the loss of CerS3 activity.
This finding is consistent with data obtained from a recent
Cers3 knockout mouse line (Jennemann et al., 2012), which
demonstrated a severe skin barrier defect leading to death of
mutant mice shortly after birth accompanied by a deficiency
in epidermal keratinization and a strong increase in
transepidermal water loss. It is still not clear in detail why
the human disease is compatible with life; however, the
discrepancy may reflect the different stages of skin
development in mice and humans at birth. The ratio of body
volume to surface is beneficial in humans compared with
rodents to reduce dehydration; moreover, the intrauterine
development of a collodion membrane in affected humans
diminishes the immediate neonatal transepidermal water loss
that is present in the mouse models of ARCI studied so far. Our
results are also corroborated by the finding of a thick, compact
stratum corneum with lipid enclosures, reduced amounts of
lamellar bodies and keratohyalin, and irregularly processed
vesicular structures in patient skin and CerS3-deficient skin
models.
From a pathophysiologic point of view, different types of
congenital ichthyosis have abnormalities in the epidermal
permeability barrier in common (Bouwstra and Ponec, 2006;
Schmuth et al., 2007; Elias et al., 2008; Oji et al., 2010). These
diseases comprise, among others, forms of ARCI including
Harlequin ichthyosis (Online Mendelian Inheritance in Man
(OMIM) 242500), a particularly severe form of nonsyndromic
congenital ichthyosis caused by mutations in ABCA12,
lamellar ichthyosis, and congenital ichthyosiform
erythroderma, which can be caused by mutations in
transglutaminase-1, 12R-LOX, eLOX-3, and others (OMIM
242100, 242300). Notably, the elongation of very long
chain fatty acids involves ELOVL4, which can be mutated in
a syndrome of ichthyosis, intellectual disability, and spastic
quadriplegia (OMIM 614457) (Aldahmesh et al., 2011).
Similarly, FATP4, which is mutated in ichthyosis prematurity
syndrome (OMIM 608649) (Klar et al., 2009), can serve as a
very long chain acyl–CoA synthetase (Jia et al., 2007), which
might be essential in late fetal development but substituted
soon after birth. Very long chain acyl–CoA and sphinganine
are then substrates of CerS3 to form (dihydro)ceramides,
which are transported from the endoplasmic reticulum to the
Golgi apparatus, glycosylated, and further transferred to
lamellar bodies. These contain membrane-bound transporter
proteins including ABCA12, which might be involved in
transport of glucosylceramides and fatty acids (Akiyama
et al., 2005), and glucosylceramides are then esterified with
linoleate (Hamanaka et al., 2002), which is provided by
hydrolysis of triacylglycerol (Uchida et al., 2010). Mutations
in ABHD5 (encoding CGI-58) can cause neutral lipid storage
disease with ichthyosis (Chanarin–Dorfman syndrome; OMIM
275630). CGI-58 has been identified as a cofactor for
triacylglyceride lipase and acts as an acyl transferase
(Montero-Moran et al., 2010; Radner et al., 2010).
Accordingly, loss of CGI-58 leads to a decrease in EOS
ceramides and bound o-hydroxylated ceramides but an
increase in free o-hydroxylated ceramides (Radner et al.,
2010; Uchida et al., 2010). Recent data have shown that
EOS ceramides are finally oxygenated in a two-step process by
12R-LOX and eLOX-3 (Zheng et al., 2011). Oxidized linoleate
is hydrolyzed and glucosylceramide deglycosylated by
b-glucocerebrosidase, which can be mutated in Gaucher
disease (OMIM 230900) (Holleran et al., 1994). Extended
ceramides are then covalently linked to the cornified envelope
by transglutaminase-1 (Nemes et al., 1999) and thus available
for the barrier formation as stacked bilayers (Iwai et al., 2012).
To conclude, our results significantly contribute to the
emerging evidence for the understanding that congenital
ichthyosis is a disorder of disturbed lipid metabolism in the
skin, regardless of the underlying genetic cause (Elias et al.,
2012). They pinpoint the specific importance of very long
chain ceramides for the epidermal differentiation and barrier
integrity and the formation of the cornified lipid envelope
(Behne et al., 2000; Uchida and Holleran, 2008). Several
diseases presenting with ichthyosis and barrier disturbance
can thus be attributed to defects of ceramide synthesis and
delivery. Further experiments are necessary to characterize the
interconnection of the proteins involved in more detail;
however, an avenue is laid open to targeted therapeutic
strategies, as a common pathological context is apparent
and disease-specific interventions are yet possible.
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MATERIALS AND METHODS
Linkage and exome sequence analysis
Peripheral blood was collected in EDTA from all available family
members and DNA was extracted using standard procedures. DNA
samples were genotyped using the Affymetrix GeneChip Human
Mapping 250K Sty Array Set. Genotypes were called by the
GeneChip DNA Analysis Software (Affymetrix, Santa Clara, CA) and
all data were handled using the graphical user interface ALOHO-
MORA (Ru¨schendorf and Nu¨rnberg, 2005). Data were checked using
the program Graphical Representation of Relationships (Abecasis
et al., 2001), and parametric linkage analysis was done with the
programs Allegro (Gudbjartsson et al., 2005) and MERLIN (Abecasis
et al., 2002). Exome sequencing was done after enrichment with the
Agilent SureSelect Human All Exome 50 Mb kit (Agilent, Santa Clara,
CA) using the Illumina GAIIx sequencing instrument (Illumina,
San Diego, CA) with a single end read 150 bp protocol (see
Supplementary Materials and Methods online).
Reverse-transcriptase–PCR
RNA was extracted from cultured keratinocytes using the RNeasy
Mini Kit (Qiagen, Hilden, Germany). Relative quantification was
performed with a one-step reverse-transcriptase–PCR protocol using
the SYBR GreenER Kit (Life Technologies, Darmstadt, Germany)
and analyzed in a LightCycler 480 Real-Time PCR System (Roche
Diagnostics, Mannheim, Germany) with reference to 18S RNA,
GAPDH, and RPS18. Primers used were as follows: CERS3 forward
(F): 50-CCAGGCTGAAGAAATTCCAG-30, and reverse (R): 50-AACGC
AATTCCAGCAACAGT-30; ALOX12B F: 50-ACCCGAGGGCAAGA
TGAT-30, and R: 50-GCAGGAAGATGGGGCAAT-30; ALOXE3 F:
50-AAGCTTCGAGGGCTGTTG-30, and R: 50-CACCAGTGCTCTGTG
ACATACTT-30.
Electron microscopy
Specimens were fixed at room temperature in 3% glutaraldehyde in
0.1 M cacodylate buffer, pH 7.4, cut into pieces of 1 mm3, washed in
buffer, postfixed for 1 hour at 4 1C in 1% osmium tetroxide, rinsed
in water, dehydrated through graded ethanol solutions, transferred
into propylene oxide, and embedded in epoxy resin (Glycidether 100,
Carl Roth, Karlsruhe, Germany). Semithin and ultrathin sections were
cut with an ultramicrotome (Ultracut E, Reichert, Go¨ttingen, Ger-
many). Ultrathin sections were treated with uranyl acetate and lead
citrate, and examined with an electron microscope (EM 900, Zeiss,
Oberkochen, Germany).
Cell culture
Biopsy specimens were used for the isolation of normal human
epidermal keratinocytes and normal human dermal fibroblasts as
described previously (Eckl et al., 2011). Normal human epidermal
keratinocytes were cultured for the first two passages on mitomycin
C–treated 3T3 J2 feeders in keratinocyte culture medium
(Allen-Hoffmann and Rheinwald, 1984); afterwards, normal human
epidermal keratinocytes were grown in the absence of feeder cells
under low Ca2þ conditions in keratinocyte grown medium (Lonza,
Verviers, Belgium) up to passage 4. Differentiated keratinocytes for
lipid analysis were obtained in keratinocyte grown medium
supplemented with 1.15 mM CaCl2 for 7 days. Normal human
dermal fibroblasts were maintained in 10% DMEM. HEK 293T cells
were cultured in DMEM supplemented with 10% fetal calf serum,
100 IU ml 1 penicillin, and 100mg ml 1 streptomycin. HEK 293T
cells were transfected using PEI reagent (Sigma, Munich, Germany).
Transient knockdown of CERS3 in keratinocytes
Knockdown of CERS3 in basal normal human epidermal keratino-
cytes was performed with 2,220 pmol of a set of three small
interfering RNAs (Life Technologies) and 150ml Lipofectamin 2000
(Life Technologies) for each T225 flask. The mixture was diluted in
Opti-MEM (Life Technologies), and cells remained in serum-free
keratinocyte grown medium (Lonza) without any antibiotics. Cells
were harvested exactly 24 hours after knockdown and then used for
skin model preparation.
Three-dimensional full-thickness skin model preparation
Skin models were prepared as described previously (Eckl et al., 2011)
with 3.5–5.2 106 keratinocytes and 0.25 106 fibroblasts not older
than passages 3 and 4, respectively. Models were cultured in the
differentiation medium keratinocyte culture medium (Rheinwald and
Green, 1974) at the air–liquid interface for 8 days. Samples were
embedded in paraffin or snap frozen. Healthy controls were matched
in age, skin type, and origin. For penetration assays, a sterile silicone
ring with a 0.8 cm inner diameter was applied and a 1 mM Lucifer
Yellow solution was poured onto the skin model. After incubation for
1 hour, models were washed excessively and samples taken using a
skin biopsy punch. Cryosections were counterstained with 4’,6-
diamidino-2-phenylindole and analyzed with a fluorescence micro-
scope (LMD 6000, Leica, Wetzlar, Germany).
Cloning of CERS3
Total RNA was extracted from differentiated keratinocytes. cDNA
synthesis was performed with oligo (dT) primers. The complete
coding sequence was amplified using Phusion DNA polymerase
(New England Biolabs, Frankfurt, Germany) and cloned using the
Gateway technology (Life Technologies). The CerS3(W15R) construct
was subcloned from wild-type CERS3 using restriction-free cloning
(van den Ent and Lo¨we, 2006). Primers used were F: 50-GGAAA
GATTCCGGCTTCCTCCAAC-30 and R: 50-GTTGGAGGAAGCCGGA
ATCTTTCC-30.
Ceramide synthase assays
Primary human keratinocytes and transfected HEK cells were homo-
genized in 20 mM HEPES-KOH, pH 7.2, 25 mM KCl, 250 mM sucrose,
and 2 mM MgCl2 containing a protease inhibitor cocktail (Sigma).
Protein content was determined using the Bradford reagent (Bio-Rad,
Hercules, CA). Homogenates were incubated with 15mM NBD-
sphinganine (Avanti Polar Lipids, Alabaster, AL), 20mM defatted BSA
(Sigma), and 50mM C26–CoA (Avanti Polar Lipids) for 20 minutes at
37 1C. Lipids were extracted and separated by thin layer chromato-
graphy using chloroform, methanol, and 2 M NH4OH (40:10:1, v/v/v)
as the developing solvent. NBD-labeled lipids were visualized using
the Typhoon 9410 variable mode imager and quantified by Image-
QuantTL (GE Healthcare, Chalfont St Giles, UK).
LC-ESI-MS/MS analysis of ceramides
Ceramides in differentiated keratinocytes were determined by LC
coupled to electrospray ionization tandem mass spectrometry (LC-ESI-
MS/MS). Cells were homogenized in water (B5 106 cells per ml)
using the Precellys 24 Homogenisator (Peqlab, Erlangen, Germany).
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The protein content of the homogenate was determined using
bicinchoninic acid. For the analysis of free (not protein-bound)
ceramides, 100ml of homogenate was spiked with 750ml of metha-
nol/chloroform 2:1 (v/v) and 200 pmol of the internal standard
ceramide 17:0 (Matreya, Pleasant Gap, PA). Lipids were extracted
overnight at 48 1C. For the analysis of ceramides bound to proteins of
the cornified envelope, 1.4 ml of homogenate was used, and ceramides
were released as described previously (Jennemann et al., 2012).
Lipid extracts were purified using a modification of the Bligh-Dyer
procedure (Signorelli and Hannun, 2002). Ceramide species
were analyzed using a previously described LC-ESI-MS/MS method
(Schwamb et al., 2012) and monitored in the positive ion mode with
their specific multiple reaction monitoring transitions (Shaner et al.,
2009; Jennemann et al., 2012). Integrated peak areas of
endogenous ceramide species were corrected against the peak area
of the internal standard ceramide 17:0 and then normalized to the
protein content.
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